Addressing the threats of HIV and emerging infectious disease to the military and global community through innovative research

Ended Cooperative Agreement Awarded Last action

Award ID
W81XWH1820040
Recipient
Awarding agency
Obligated
$800,631,761

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
Westlake, MD 20817, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $47,993,521
Amendment $274,238
Amendment $3,112,052
Amendment $26,180,595
Amendment -$3,063,000
Amendment -$3,251
Amendment $46,211,756
Amendment Correcting the amount from previous faadcs. The original DE-obligation amount for this is $376,029.04. -$579,493
Amendment $1,153,007
Amendment $597,010
Amendment $17,893,270
Amendment $32,022,199
Amendment $7,966,701
Amendment 1. Provides incremental funding via PR 0011888098 in the amount of $43,234,683.92. The obligated amount has increased from $577,435,008.41 to $620,669,692.33.2.… $43,234,684
Amendment $24,809
Amendment The purpose of this modification is to add funding in the amount of $19,287,769.02. The obligated amount has increased from $558,122,430.39 to the new amount of… $19,287,769
Amendment The purpose of this modification is to add funding in the amount of $5,969,733.61. The obligated amount has increased from $552,152,696.78 to the new amount… $5,969,734
Amendment The purpose of this modification is to add funding in the amount of $1,215,851.02 and DE-OB funding in the amount of ($203,464.04) clin 0002/43. The obligated… $1,215,851
Amendment The purpose of this modification is to add funding in the amount of $51,798,787.73. The obligated amount has increased from $499,341,522.07 to the new amount of… $51,798,788
Amendment The purpose of this modification is to add funding in the amount of $26,687,081.49. The obligated amount has increased from $472,654,440.58 to the new amount of… $26,687,081
Amendment The purpose of this modification is to add funding in the amount of $3,723,701.49. The obligated amount has increased from $468,930,739.09 to the new amount… $3,723,701
Amendment The purpose of this modification is to add funding in the amount of $25,994,157.75. The obligated amount has increased from $442,936,581.34 to the new amount of… $25,994,158
Amendment $21,378,596
Amendment $49,144,054
Amendment $4,647,122
Amendment $68,283,975
Amendment Covid-19 addressing the threats of HIV and emerging infectious disease to the military and global community through innovative research. The purpose of this… $17,609,861
Amendment $0
Amendment $42,141,094
Amendment Covid-19 addressing the threats of HIV and emerging infectious disease to the military and global community through innovative research. The purpose of this… $25,918,349
Amendment Modification to add funding, approve exempt equipment, and adds new subawards. $8,780,076
Amendment Modification to add funding $11,258,162
Amendment Modification to add funding and to add world vision, INC. As a new sub awardee. $39,864,090
Amendment $6,871,590
Amendment $43,240,658
Amendment $29,158,099
Original award $74,640,855
Show all 42

Subawards

Subrecipient Amount Awarded
University Of Maryland, Baltimore Research on isolating shark-derived nanobodies for use in the detection and potential treatment of disease due to arenavirus infection $40,000
Beth Israel Deaconess Medical Center, Inc. The study will evaluate: a) the immunogenicity of the WRAIR/HJF ALFQ adjuvanted SpFN XBB.1.5 vaccine delivered by the IM, IN, and IT routes, either as a prime… $600,000
The Trustees Of Columbia University In The City Of New York Phase 1b Clinical Trials of a Novel Long-Acting Bispecific Antibody to inform HIV prevention (RV584 and RV610) $130,061
University Of Florida SCOPE OF WORK Dr. von Fricken will provide epidemiological oversight on study implementation, contributing to the Data Analysis pipeline utility assessments,… $49,872
Search Research Foundation RV582 - Safety and efficacy of broadly neutralizing antibodies followed by innate immune stimulation and therapeutic vaccination for the induction of HIV… $294,997
Search Research Foundation Characteristics of immunity in gut mucosa, spinal fluid, lymph node and blood of HIV negative and HIV positive Thais (RV304) $2,596,879
Universitätsklinikum Essen (Anstalt DES Öffentlichen Rechts) execution of the BRAHMS study (RV500): LONGITUDINAL INCIDENCE STUDY IN SUBTYPE B-PREVALENT REGION AMONG MEN WHO HAVE SEX WITH MEN AT RISK FOR HIV INFECTION TO… $199,047
Makerere University Walter Reed Program LIMITED The scope of work for the Protocol will include, but is not limited to the following: maintenance, responsibility and oversight of the site and clinical… $476,428
Search Research Foundation Safety and Virologic Outcomes after HIV Remission Trials in Thai Patients who Initiated Antiretroviral Therapy During Early Acute HIV Infection (RV412) $203,437
Search Research Foundation RV254: Establish and Characterize an acute HIV infection cohort in a high risk population $3,891,013
Southwest Research Institute The overall objective of this project is to identify FDA approved drugs with antiviral activity against Crimean Congo Hemorrhagic fever virus (CCHFV), Lassa… $69,517
George Mason University GMU-epidemiological oversight and other support for REDINET Phase 2 $106,956
Beth Israel Deaconess Medical Center, Inc. Heterologous Platform Prime-Boost SARS-CoV-2 Vaccination in Macaques $1,296,508
HJF Medical Research International Inc. Inlap-eidb $10,448,726
Institute Of HIV Research And Innovation Foundation Establish and Characterize an acute HIV infection cohort in a high risk population - RV254 $3,421,171
Institute Of HIV Research And Innovation Foundation Characteristics of immunity in gut mucosa, spinal fluid, lymph node and blood of HIV negative and HIV positive Thais (RV304) $95,030
Institute Of HIV Research And Innovation Foundation Safety and Virologic Outcomes after Analytic Treatment Interruption in Thai Patients who Initiated Antiretroviral Therapy During Early Acute HIV Infection… $179,282
MOI University College Of Health Sciences This work will enable the CRC based in Eldoret, Kenya to contribute to function in the capacity of Clinical Research Site (CRS) in the AIDS Clinical Trial Group… $979,002
HJF Medical Research International Inc. KENYA- Preclinical and Translational Research $319,123
HJF Medical Research International Inc. Kenya PEPFAR $212,193
World Vision Inc. Addressing the Threats of HIV and Emerging Infectious Disease to the Military and Global Community through Innovative Research. $1,940,520
George Washington University (The) Isolation of conformation-specific monoclonal antibodies to SARS-CoV-2 $132,210
Institute Of HIV Research And Innovation Foundation Randomized, Double Blind Evaluation of Late Boost Strategies with IHV01 (FLSC in aluminum phosphate) and A244 with or without ALFQ for HIV-uninfected… $20,652
Makerere University Walter Reed Program LIMITED Uganda Lab Capacity $1,036,101
HJF Medical Research International Inc. Kenya CTU $566,711
HJF Medical Research International Inc. Mozambique CTU $276,772
HJF Medical Research International Inc. Nigeria Preclinical and Translational Research $94,580
HJF Medical Research International Inc. Kenya Clinical Development $2,233,978
HJF Medical Research International Inc. Jordan EIDB Prime $53,588
University Of Missouri System Study of Neuro HIV Cure Consortium (Protocols: RV254, RV397, RV398, RV405, and RV412. $233,469
University Of Maryland, Baltimore The goal of this project is the isolation of shark-derived binding domains (�VNARs�) for use in the detection of SARS-CoV-2. To this end 2 nurse… $294,545
The Trustees Of Columbia University In The City Of New York HIV Immunoprophylaxis with bispecific antibody $1,016,879
HJF Medical Research International Inc. EID016/RV505-Comtemporary Epidemiology of HIV in Jordan $299,916
Sante Quebec Centre Hospitalier De L'universite De Montreal RV254, RV412 Studies $27,400
HJF Medical Research International Inc. RV 466 $341,173
HJF Medical Research International Inc. Pepfar kenya $10,985,170
HJF Medical Research International Inc. Inlap-eidb $36,159,538
HJF Medical Research International Inc. Navrongo Integrated Surveillance Project (NISP)/EID031 $40,131
HJF Medical Research International Inc. MHRP Mozambique $278,014
HJF Medical Research International Inc. Tanzania PEPFAR $73,259,408
HJF Medical Research International Inc. Liberia Clinical Development $1,023,242
Redeemer's University EID032 Incidence of Lassa Virus Infection in Southern Nigeria $3,184,405
Institute Of HIV Research And Innovation Foundation Safety and Virologic Effect of a Human Monoclonal Antibody, VRC- HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously… $68,782
Makerere University Walter Reed Program LIMITED PEPFAR several protocol $31,507,871
The HIV Netherlands Australia Thailand Research Collaboration Reducing HIV persistence in lymph nodes by Interleukin-15 (IL-15) Receptor super-agonist (N-803) in Individuals with Acute HIV Infection (RV550) $288,285
HJF Medical Research International Inc. Nigeria Preclinical and Translational Research $112,894
National Institute For Medical Research This contract will enable the NIMR-MMRC, Mbeya � Tanzania to continue to function in the capacity of a Clinical Research Site (CRS) in the HIV Vaccine… $617,876
Trustees Of Boston University Boston University’s Contributions to the Enhanced Mentor Mother Program (EMMA) Study for USG FY2021-22. $67,729
University Of Maryland, Baltimore Antibody Recovery from Shark Immunization with Recombinant SARS-CoV-2 Spike Protein Subunits and DNA $241,680
Instituto Nacional De Saúde Doutor Ricardo Jorge, I.p. Clinical Trails Unit (CTU) $508,659
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Quick answers

Who received award W81XWH1820040?

W81XWH1820040 was awarded to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. by Defense Health Agency (Department of Defense) on September 30, 2018.

How much is award W81XWH1820040 worth?

$800,631,761 has been obligated on W81XWH1820040.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login